Compare with Coloplast AS


Market capitalization
‪14.95 B‬ USD
0.19 USD
‪538.05 M‬ USD
‪4.12 B‬ USD
Beta (1Y)
0.84
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Company info


CEO
Gavin Wood
Headquarters
Humlebaek
Founded
1954
IPO date
Jan 1, 1983
ISIN
US19624Y2000
CUSIP
19624Y200
FIGI
BBG00TN4ZY09
Identifiers
ISIN US19624Y2000
Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateMay 19, 2030
Coupon2.75% (Fixed)
Maturity dateMay 19, 2027
Coupon2.25% (Fixed)

See all CLPBY bonds 

Weight0.13%
Market value‪1.50 M‬
Weight0.04%
Market value‪96.90 K‬
Weight0.02%
Market value‪17.71 K‬

Explore more ETFs